ASMB (Assembly Biosciences) Kacepetan wutah bathi saben saham ing taun lumaku

ASMB (Assembly Biosciences) - tandha merek perusahaan

Assembly Biosciences optimizes the synthesis of trial batches through a network of external laboratories, ensuring supply flexibility. The company's revenues are based on the development of advanced therapies for chronic hepatitis B. The YoY EPS volatility reflects the earnings per share dynamics, where the latest value is recorded as -10.40. Analysis of this trend confirms expansion into global hepatology through innovative capsid inhibitors.

ASMB (Assembly Biosciences, Inc.) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 10.11.2026

Rincian analitis lan laporan data perusahaan Assembly Biosciences (ASMB)

- rega saham lan konsensus proyeksi valuasi:
Bagan rega Assembly Bio|ASMB - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar Assembly Corp|ASMB - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham Assembly Biosciences|ASMB - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku assemblybio.com|ASMB - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Koefisien Total Utang marang Modal Assembly Biosciences|ASMB - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal assemblybio.com|ASMB - Gunggung utang perusahaan|Utang-utang marang nilai buku Assembly Corp|ASMB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Assembly Biosciences|Likuiditas cepet assemblybio.com
- indikator pendapatan resik lan kelipatan nilai:
ASMB - Bathi resik perusahaan|Bathi sing dikarepake Assembly Biosciences|ASMB - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi Assembly Corp|ASMB - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Assembly Corp|ASMB - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Assembly Biosciences|ASMB - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan assemblybio.com|ASMB - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Assembly Biosciences
Pambiji fundamental:ASMB Assembly Bio
Produk seri Assembly Biosciences, Inc.

For an investor in Assembly Biosciences (ASMB), controlling R&D cost efficiency is critical given the heavy reliance on external contractors (CRO/CMO). This metric measures the annual dynamics of net earnings per share, reflecting the actual return on capital over a cycle. By analyzing the annual EPS growth trend, one can identify stagnation phases or the risk of capital being frozen during periods of sideways price action.

Pesaing utama

ARWR (Arrowhead Pharma) - Wutah bathi saben saham ing taun lumaku|MIRM (Mirum Pharma) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku dynavax.com DVAX|Wutah bathi saben saham ing taun lumaku Arbutus Biopharma (ABUS)|IVA (inventivapharma.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku GYRE (Gyre Therapeutics)|Wutah bathi ing taun lumaku Galectin Therapeutics, Inc. GALT|GNFT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki DURECT Corporation DRRX|aligos.com (ALGS) - Wutah bathi saben saham ing taun lumaku|BIVI - Prakiraan wutah bathi resik saben saham ing taun iki|GLMD (Galmed Pharmaceuticals Ltd) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku ENDRA Life Sciences Inc NDRA|Wutah bathi saben saham ing taun lumaku Hepion Pharmaceuticals (HEPA)